SEANOL® TECHNOLOGY

  

  

Screening, Isolation and Identification of Bioactives from the Sea

Marine phytochemicals have been screened and isolated from 300 species of marine algae. The molecular structures of these phytochemicals have been identified by using state-of-the-art 2D-NMR and mass spectrometric techniques.

Learn more
about thumb

80

Scientific Studies

18

Clinical Trials

40

Patents

100

Products

Evaluating the Medicinal Efficacy and Safety of Bioactives from the Sea

To evaluate the medicinal efficacy and safety of these newly found marine phytochemicals, 80+ in vitro and in vivo studies have been carried out.

In non-pharmaceutical fields, 18 clinical trials have been carried out for the health benefits of SEANOL® supplementation in various forms including capsules, tablets, beverages, creams and hair tonics.

In the pharmaceutical field, Phase I and II studies have been carried out for PH100, an investigational new drug.

skill area thumb

Chemistry, Manufacturing and Control

High-Precision extraction and control of marine bioactives under ISO 22,000 (German Cert) using renewable, ecologically beneficial resources.
Meets industry standards of Japan, USA and EU. Uses renewable, ecologically beneficial resources.

service thumb service thumb service thumb

Wide Scope of Applications

Marine phytochemicals' extraordinary biocompatiblity and phyiological benefits have been demonstrated through the development and testing of over a hundred products including various foods, beverages, nutraceuticals, cosmetics and personal hygiene products. Now their value is becoming apparent in medical fields as well, where both safety and efficacy are urgently needed to slow down or stop the progression of many chronic illnesses.

Learn more

Approvals

Service Thumb

FDA Authorization as NDI

In 2008, the US FDA authorized the use of the Ecklonia cava extract that meets the specification of Botamedi's SEAPOLYNOL®(SEANOL®-P) as a new dietary ingredient (NDI).

  

  

Service Thumb

EFSA Authorization as NFI

In 2018, the EU authorized the use of Botamedi's SEAPOLYNOL® as a novel food ingredient (NFI) after a thorough review of its quality and safety standards by the 28 member countries and the EFSA (European Food Safety Authority).

  

Service Thumb

Health-Functional Approvals

In 2013, the Korean FDA (currently MFDS) approved Botamedi's SEAPOLYNOL® as a new health-functional food ingredient for cholesterol management.

In 2018, a health claim for the management of post-prandial blood glucose level has additionally been approved .

We provide marine phytochemical-based therapeutics that are safe, effective, and beneficial for human, animal and ecological well-being.

We pursue the triple happiness - for ourselves, our partners, and our customers.

We aim to establish a new-paradigm therapeutic approach based on both safe and effective marine phytochemicals, in order to prevent and manage the currently-incurable chronic degenerative diseases that have prevailed in the 21st century.

LEARN MORE ABOUT SEANOL®

  

Seanol Science Center